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I. INTRODUCTION
Cancer causes 550.000 deaths in the United States every year, and the treatment of canccr is an actiw research area. Medical experts explore new treatment methods, such as drugs, surgery tcchniques, and radiation thcrapics. An experiment with a new treatment procedure is called a climcal trial. Whcn researchers conduct a trial, they rccmit patients with an apprcpriate cancer typc and medical history. The selection of patients has traditionally been a manual procedm, and srudics havc s h w n that clinicians can miss up to 60% of the cligiblepaticnts [12, 22, 301.
A reccnt project at the Univcrsity of South Florida has been aimed at automatic selection of patients for clinical trials. We havc developed an intelligent agent that prompts a clinician for a patient's data and identifies all matching trials 11, 111. It includes a knowledge base with information about available clinical trials, criteria for selecting patients, and related medical tests.
We r c p a t the work on a w e b b m d interface that enablcs a clinician to enter ncw trials without the help of a programmer. Wc havc uscd the interface to build a knowledge base for clinical trials at the Moffitt Cancer Center, located at the University of South Florida We review the previous work on medical expert systems (Scction II), explain the knowledge representation in the developed agent (Section III), and dcscribc the interface for adding ncw knowledge (Section 1").
PREVIOUS WORK
Researchers began to work on medical applications of artificial intelligcnce in the early sewnties. 
KNOWLEDGE BASE
Physicians at the Moffitt Cancer Center have about 150 clinical trials available for cancer patients. They havc identified criteria that determine a paticnt's eligihility for each trial, and they use these criteria to select trials for eligible patients. Traditionally, physicians have selected trials by a manual analysis of patients' d a t a The review of resulting selections has shown that they usually do not check all clinical trials and occasiondly misr an appropriatc trial.
To addrcss this problem, we have built an intelligent agent that helps to select trials for each patient. It prompts a clinician to enter the results of medical tests, and uses thcm to identify appropriate trials.
In Figurc l(a), we givc asimplified exampleof eligibility criteria for a clinical trial. This trial is for young and (a) Eligibility criteria We encode the eligibility for a clinical trial by a logical expression, which may include variables that r e p resent the available medical data, a well as equalities, inequalities, "set-element" relations, conjunctions, and disjunctions. For example, we encode the criteria in Figure I (a) by the expression in F i b r e l(c).
The agent collectsdata until it can determine whether the eligibility expression is TRUE or FALSE. For instance, if a patient's sex is MALE, then the expression in Figure I(c) (Figure 2) , and the secand is for eligibility criteria (Figure 3 ). The interface includes ten screens; two of them are "start sueens," which can be reached from any other wren. We give an example of entering eligibility criteria, describc the two parts of the interface, and present experiments on its effectiveness.
Example: Suppose that a user needs to enter the criteria shown in Figure 1 . First, she utilizes the "Adding tests" screen to enter the three tests (Figure 4) . Then, she adds the related questions; to enter questions for a specific test, she selects the twt and clicks Wmli7y" (Figure 4) , and the agcnt displays the "Modifying a test" screen ( Figure 5 ). To add a question, she cli& the appropriate button at the bottom ( Figure 5 ) and then types the question (Figure 6 ).
After adding the questions for all tests, the user goes to the *Adding c l i n i d t d " Screcn and initializes a new trial (Figure 7) . She gets the "Selecting tests" screen and chooses the tests related to thc current trial (Figure 8 ). Then, she marks relevant questiom and the answers that make a patient eligible (Figure 9 ). If the eligibility criteriaindude disjunctions, she has t o w the screen for composing logical exprssions ( Figure IO ).
Tests and questions: The interface for adding tests and qucstions includes six screens (Figure 2 ). The start screen is for viewing the available tests and dcfining new ones, whereas the other screens are for modifying tests and adding questions We show the start screen in Figure 4 
Deleting questions
Delete quesions -View all questions We show thc screens for adding &no and multiplechoice questiorm in Figure 6 : thc screen for numeric questions is similar Thc USET can enter B new question for thc current test, along with a set of allawd m r s . If the question is also d a t e d to other tests, the user hss to mark them in thc laver box. Thc aDeletmg pwtions~s screen is for rcm.ming old questions.
Eligibility conditions: The rncchanism for entering eligibility criteria consists of four screens (Figure 3) . The start screcn allows the user to initialize a new clinical trial and view the criteria for old trials. If the displays the t e s t s e l e c t a n screen (Figure 8) . The user then chooses related tests and question types, and clicks *Continue" to get the question list.
The next screen (Figure 9) sclected criteria. If the eligibility conditions involve a more complex cxpression, thc m e r has to click "Cornbtned question" and then usc the screen for composing logical cxprcssions ( Figure IO ).
Entry time:
We have run cxperiments with sixteen novice users, who had no prior expcrisnce with the interface. First, every user has cntcrcd four sets 01 medical tcsts; cach sct has includcd thrm tcsts and ten q u e tions. Then, cach user has added eligibility expressions for ten clinical trials used at the Moffitt Cancer Center; the number of questions in an eligibility expression has varied from ten to thirty-fivc.
W e have mcasured the entry time for each test set and each eligibility exprczsion. In Figure 11 , we show the mean time for every test sct and thc time per question for the same sets. All uscrs have entered the test sets in the Same order, from 1 to 4; since they had no prior expcriencc, their pcrformance has improved during the cxperiment. In Figurc 12, we give similar graphs for the entry of eligibility expressions.
The experiments have shown that novices can efficiently use the interface; they quickly lcarn its full functionality, and their learning c u m flattcns aftcr about an hour. The avcragc time pcr question is 31 sceonds for thc entry of medical tests and 37 seconds for elmbility criteria, which means that a user c m enter all 150 cancer trials used at Maffitt in about two weeks.
V. CONCLUDING REMARKS
We have developed knowledge-acquisition tmls for an agent that automatically assigns cancer patients to clinical trials. We have described the rcprescntation ofeligibility criteria and a webbased interim for adding now trials. The experiments have shown that a user can enter a new trial in fifteen to thirty minutes. Novices can use the interface without prior instructions, and they reach their full speed after about an hour. Although cancer researdl at Moffitt has provided the motivation for this work, the agent is not limited to cancer, and we can use it for trials related to other diseases.
